Search results
Results From The WOW.Com Content Network
Year to date, Moderna stock has plunged over 60%, with a 52-week low-high of $35.8-$170.47, as per data from Benzinga Pro. Recently, Moderna and several other stocks witnessed a decline as Robert ...
Moderna stock fell over 9% on Wednesday, forfeiting most of its gains from Tuesday's session during a volatile week for the stock seen after the first reported bird flu death in the US, which put ...
Moderna stock gained 14%, shooting up to $48.56 per share Tuesday afternoon. Vaccine-makers Novavax and CureVac similarly rose, soaring 15% and 10%, respectively, while Pfizer gained 2% and GSK ...
Moderna's stock slid more than 20% in early trading Monday on the news to $33.05 per share — a fraction of its COVID highs of nearly $450 per share in 2021.
To find out, let's look at some reasons the stock fell despite the good news. Why Moderna stock fell Moderna's bizarre stock price performance during the week ending May 31 had two main factors.
Moderna Inc (NASDAQ: MRNA) is trading lower Monday morning after the U.S. Food and Drug Administration delayed approval of the company's Emergency Use Authorization request for the use of its ...
The stock made an attempt to settle below the $140 level.
The company's stock was trading slightly up on the news early Monday before falling after market open. Moderna is up almost 20% in the last month after the company received approval from the FDA ...